Are there still advantages to conducting clinical trials in Ukraine?

By Euromed

Over the past ten years, the number of clinical trials in Ukraine has enjoyed rapid growth, but political upheaval and other challenges in this emerging market risk deterring companies from developing trials within the country. Nataliia Bazylevych, business development manager at SMO Group explains why Ukraine is still a prime clinical trials destination with many competitive benefits to offer.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.